CLINICAL RESEARCH: HEART RHYTHM DISORDERS
Mortality Trends in Patients Diagnosed With First Atrial FibrillationA 21-Year Community-Based Study
Yoko Miyasaka, MD, PhD, FACC*,
Marion E. Barnes, MSc*,
Kent R. Bailey, PhD ,
Stephen S. Cha, MS,
Bernard J. Gersh, MB, ChB, DPhil, FACC*,
James B. Seward, MD, FACC* and
Teresa S.M. Tsang, MD, FACC*,*
* Division of Cardiovascular Disease and Internal Medicine
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota
Manuscript received March 27, 2006;
revised manuscript received October 19, 2006,
accepted October 23, 2006.
* Reprint requests and correspondence: Dr. Teresa S. M. Tsang, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. (Email: tsang.teresa{at}mayo.edu).
OBJECTIVES: The purpose of this study was to assess the mortality trends of atrial fibrillation (AF) in a community.
BACKGROUND: Limited data exist regarding the mortality trends of patients diagnosed with first AF.
METHODS: A community-based cohort of adult residents of Olmsted County, Minnesota, who had electrocardiogram-confirmed first-documented AF in the years 1980 to 2000 were identified and followed to 2004 or death. The primary outcome was all-cause mortality.
RESULTS: Of a total of 4,618 residents (mean age 73 ± 14 years) diagnosed with first AF, 3,085 died during a mean follow-up of 5.3 ± 5.0 years. Relative to the age- and gender-matched general Minnesota population, the mortality risk was increased (p < 0.0001) with a hazard ratio (HR) of 9.62 (95% confidence interval [CI] 8.93 to 10.32) within the first 4 months and 1.66 (95% CI 1.59 to 1.73) thereafter. Cox proportional hazards modeling showed no change in overall age- and gender-adjusted mortality (HR for the year 2000 vs. 1980: 0.99; 95% CI 0.86 to 1.13; p = 0.84), even after adjustment for comorbidities. In secondary analyses, no changes in mortality were seen for early (within first 4 months) or late (after 4 months) mortality for the entire group or within the subgroup of patients who did not have cardiovascular disease at baseline.
CONCLUSIONS: In this cohort of patients newly diagnosed with AF, mortality risk was high, especially within the first 4 months. There was no evidence for any significant changes over the 21 years in terms of overall mortality, early or late mortality, or mortality among patients without pre-existing cardiovascular disease.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CI = confidence interval | | HR = hazard ratio |
|
This article has been cited by other articles:
|
|
|
|
 
K. Wachtell, R. B. Devereux, P. A. Lyle, P. M. Okin, and E. Gerdts
The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy
Therapeutic Advances in Cardiovascular Disease,
December 1, 2008;
2(6):
507 - 513.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. S. Taggar, F. Marin, and G. Y.H. Lip
Mortality in patients with atrial fibrillation: improving or not?
Europace,
April 1, 2008;
10(4):
389 - 390.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation,
January 29, 2008;
117(4):
e25 - e146.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M. Krumholz and F. A. Masoudi
The Year in Epidemiology, Health Services Research, and Outcomes Research
J. Am. Coll. Cardiol.,
December 4, 2007;
50(23):
2254 - 2262.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Other articles noted
Evid. Based Med.,
August 1, 2007;
12(4):
127 - 128.
[Full Text]
[PDF]
|
|
|
|
